Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction

References

• Alpert JS, Thygesen K, Antman E, Bassand JP. The Joint European Society of Cardiology/ American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Com-mittee for the redefinition of myocardial infarc-tion. J Am Coll Cardiol 2000; 36: 959— 69.
   PubMed Web of Science ®Google Scholar
• Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin inhibition in myocardial ischemia. Circulation 1997; 96: 2578–85.
   Google Scholar
• Watnick S, Perazella MA. Cardiac troponins: utility in renal insufficiency and end-stage renal disease. Semin Dial 2002; 15: 66–70.
   PubMed Web of Science ®Google Scholar
• Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, Moatti N, Buisson C, Jacquot C. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: chronic haemodia-lysis and new cardiac markers evaluation (CHANCE) study. Nephrol Dial Transplant 2001; 16: 1452–8.
   Google Scholar
• L6wbeer C, Ottosson-Seeberger A, Gustafsson SA, Norrman R, Hulting J, Gutierrez A. Increased cardiac troponin T and endothelin-1 concentra-tions in dialysis patients may indicate heart disease. Nephrol Dial Transplant 1999; 14: 1948— 55.
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, Bonanno G, Fatuzzo P, Rapisarda F, Seminara G, Stancanelli B, Bellanuova I, Cataliotti A, Malatino LS. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002; 40: 68–75.
   PubMed Web of Science ®Google Scholar
• Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J 1999; 138: 95–9.
   PubMed Web of Science ®Google Scholar
• La Vecchia L, Mezzena G, Zanolla L, Paccanaro M, Varotto L, Bonanno C, Ometto R. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 2000; 19: 644–52.
   PubMed Web of Science ®Google Scholar
• Setsuta K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada A, Takano T, Kishida H, Hayakawa H. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999; 84: 608 — 11, Abstr. 9.
   Google Scholar
• Perna ER, Macin SM, Parras JI, Pantich R, Farias EF, Badaracco JR, Jantus E, Medina F, Brizuela M. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am Heart J 2002; 143: 814–20.
   Google Scholar
• Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Due P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161–7.
   PubMed Web of Science ®Google Scholar
• Kjaer A, Hesse B. Heart failure and neuroendo-crine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001; 21: 661— 72.
   PubMedGoogle Scholar
• Yousufuddin M, Henein MY, Flather M, Wang D, Shamim W, O'Sullivan C, Kemp M, Kazzam E, Banner NR, Amrani M, Coats AJ. Incremental importance of peak-exercise plasma levels of endothelin-1 and natriuretic peptides in chronic heart failure. J Cardiovasc Pharmacol 2001; 38: 468— 73.
   Google Scholar
• Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H. Risk stratifica-tion using a combination of cardiac troponin T and brain natriuretic peptide in patients hospita-lized for worsening chronic heart failure. Am J Cardiol 2002; 89: 691–5.
   PubMed Web of Science ®Google Scholar
• Sato Y, Taniguchi R, Makiyama T, Nagai K, Okada H, Yamada T, Matsumori A, Takatsu Y. Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decom-pensation. Heart 2002; 88: 647–8.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Lutas EM, Casale PN, Kligfteld P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222 — 30.
   PubMed Web of Science ®Google Scholar
• Alam M, Rosenhammer G. Atrioventricular plane displacement and left ventricular function. J Am Soc Echocardiogr 1992; 5: 427–33.
   PubMedGoogle Scholar
• Hammarstrom E, Wranne B, Pinto FJ, Puryear J, Popp RL1. Tricuspid annular motion. J Am Soc Echocardiogr 1991; 4: 131 — 9.
   PubMedGoogle Scholar
• de Simone G, Devereux RB, Celentano A, Roman MJ. Left ventricular chamber and wall mechanics in the presence of concentric geometry. J Hyper-tens 1999; 17: 1001–6.
   Web of Science ®Google Scholar
• Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac Troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest 1999; 59 Suppl 230: 128–31.
   Google Scholar
• Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, Kataoka K, Ito H, Matsumori A, Sasayama S, Takatsu Y. Persis-tently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse out-comes. Circulation 2001; 103: 369–74.
   Google Scholar
• Lundback S. Cardiac pumping and function of the ventricular septum. Acta Physiol Scand 1986; 550 Suppl: 1–101.
   Google Scholar
• Ooi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem 2000; 46: 338–44.
   Google Scholar
• Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953–8.
   Google Scholar
• Logeart D, Beyne P, Cusson C, Tokmakova M, Leban M, Guiti C, Bourgoin P, Solal AC. Evidence of cardiac myolysis in severe nonis-chemic heart failure and the potential role of increased wall strain. Am Heart J 2001; 141: 247 — 53.
   PubMed Web of Science ®Google Scholar
• Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC Jr, Cruickshank JM, Devereux RB, Giles TD, Korsgaard N, Leier CV, Mendelsohn FAO, Motz WH, Mulvany MJ, Strauer BE. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 1992; 20: 3–16.
   PubMed Web of Science ®Google Scholar
• Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849–65.
   Google Scholar
• Maruyama Y, Saito T, Maehara K. Coronary circulation in the failing heart. Jpn Heart J 1997; 38: 755–67.
   Google Scholar
• Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182–9.
   PubMed Web of Science ®Google Scholar
• Wu AH, Ford L. Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin Chim Acta 1999; 284: 161–74.
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402–12.
   Google Scholar
• Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988–94.
   PubMed Web of Science ®Google Scholar
• Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunc-tion. Circulation 1997; 96: 509–16.
   Google Scholar
• Hetmanski DJ, Sparrow NJ, Curtis S, Cowley AJ. Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community. Heart 2000; 84: 440–1.
   PubMed Web of Science ®Google Scholar
• McClure SJ, Caruana L, Davie AP, Goldthorp S, McMurray JJ. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. Br Med J 1998; 317: 516 — 9.
   Google Scholar
• Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 1997; 36: 246–55.
   PubMed Web of Science ®Google Scholar
• Potluri S, Ventura HO, Mulumudi M, Mehra MR. Cardiac troponin levels in heart failure. Cardiol Rev 2004; 12: 21–5.
   PubMedGoogle Scholar
• Del Carlo CH, Pereira-Barretto AC, Cassaro-Strunz C, Latorre Mdo R, Ramires JA. Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure. J Card Fail 2004; 10: 43–8.
   PubMed Web of Science ®Google Scholar
• Ishii J, Cui W, Kitagawa F, Kuno T, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Nagamura Y, Kondo T, Oshima H, Nomura M, Ezaki K, Hishida H. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem 2003; 49: 2020— 6.
   PubMed Web of Science ®Google Scholar